#$%^&*AU2013263769A120131219.pdf#####H:\rbr\Intrwovn\NRPortbl\DCC\RBR\5852045_I.DOC-28/11/2013 ABSTRACT The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.